Blue Light Emitting Diode Therapy on Vulvovaginal Candidiasis
Recurrent Vulvovaginal Candidiasis
About this trial
This is an interventional treatment trial for Recurrent Vulvovaginal Candidiasis
Eligibility Criteria
Inclusion Criteria: subject selection will be according to the following criteria: Age will range between 18- 50 years. All patients will be confirmed by culture and examination of fresh vaginal samples, to have VVC. All patients who will be enrolled to the study will have their informed consent. Exclusion Criteria: The participants will be excluded if they meet one of the following criteria: Individuals on any other antifungal drugs. Individuals with cardiopulmonary conditions. Individuals undergoing another radiation therapy. Sensory impairment
Sites / Locations
- Faculty of physical therapy, Cairo University
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Group A
Group B
This group includes 30 patients will receive routine medical treatment with antifungal, azole (vaginal route). 100 ml ( one Suppository ) at bedtime for three nights in a row
This group includes 30 patients. The vulva and vagina will be exposed to 401 ± 5 nm ultraviolet A/ blue LED irradiation in a single session, divided into two applications.